In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs.
The following faculty have disclosed:
Jan Beyer-Westendorf, MD, PhD, chair for this educational event, received research funding from Bayer, Boehringer Ingelheim, Daiichi Sankyo, Pfizer, and Alexion/AstraZeneca; and received consulting fees from Bayer, Daiichi Sankyo, DOASENSE, Norgine, Pfizer, Takeda, and Alexion/AstraZeneca.
Craig I. Coleman, PharmD, FASHP, faculty for this educational event, research funding from Bayer AG, AstraZeneca Pharmaceuticals, and Janssen Scientific Affairs, LLC; and received consulting fees from Bayer AG, AstraZeneca Pharmaceuticals, and Janssen Scientific Affairs, LLC.
Paul Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP, faculty for this educational event, received consulting fees from The Pfizer/BMS Alliance, AstraZeneca, and Janssen Pharmaceuticals.
Deborah Siegal, MD, MSc, FRCPC, faculty for this educational event, has no relevant financial relationships with ineligible companies.